Posted by Michael Wonder on 05 Feb 2024
Linzagolix choline for the treatment of patients with moderate to severe symptoms of uterine fibroids
5 February 2024 - The Department of Health and Social Care has asked the NICE to produce guidance on the use of linzagolix choline in the NHS in England.
Linzagolix choline lis recommended as an option for the treatment of adults of reproductive age with moderate to severe symptoms of uterine fibroids only if they cannot have or do not want to be treated with hormonal replacement add-back therapy.
